Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.7.0 is added to the page. A large set of study documents and related items, including Informed Consent Form entries and the Study Protocol/SAP, were removed from the Study Documents section.SummaryDifference18%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page metadata now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a small release version update.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.6.5 replaces the previous v3.6.4 in the page's revision line. This represents a minor update to the study record without changes to the trial design, results, or eligibility criteria.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a minor update to the page template or rendering.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating a new version of the page. This typically accompanies minor content or metadata updates rather than changes to the trial data.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page revision tag changed to v3.6.2, indicating a minor maintenance update to the page.SummaryDifference0.1%

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.